Hospitals and health systems have the most to gain from AI and the most complexity to manage — many systems, strict regulation, and thousands of people to bring along. The technology is rarely the bottleneck; governance, integration, and adoption are. Here’s how to adopt AI at scale, and how dgm implements it. (dgm implements osFoundry, a separate company’s platform — we are not osFoundry; clinical and compliance decisions stay with your teams.)
What AI actually does at hospital scale
The honest framing: the wins are real but the hard part is operationalizing them across a large, regulated organization. Three categories dominate: ambient documentation, revenue-cycle automation, and FDA-regulated imaging/diagnostic AI. Getting value from any of them at scale depends on governance, integration, and adoption far more than on the model.
High-value use cases
- Ambient clinical documentation — among the fastest-adopted clinical technologies, easing clinician documentation burden across departments (with clinician review).
- Revenue-cycle automation — coding assistance, eligibility checks, and denial prediction.
- Imaging and diagnostic AI — the largest FDA-authorized AI-device category; these are regulated devices.
- Enterprise knowledge and operations — search and automation across the system’s vast information.
The compliance and governance reality
At scale, the guardrails are non-negotiable:
- HIPAA / BAAs — every AI vendor touching PHI is a business associate needing a BAA; the BAA should restrict training on your PHI.
- FDA device line — imaging/diagnostic AI is generally a regulated device; administrative AI usually isn’t.
- 42 CFR Part 2 — if you run SUD programs, substance use disorder records carry heightened protection (updated-rule enforcement began February 2026).
- The prior-auth caveat — AI that speeds coding can trigger payer downcoding and an administrative back-and-forth; measure net outcomes, not just processing speed.
dgm designs governance — access controls, audit trails, human oversight — in from the start (see AI Security & Governance Consulting); clinical and compliance determinations stay with your teams.
Scaling the right way
The riskiest move at a health system is a big-bang rollout. The pattern that works is pilot-to-scale: prove value and controls on a contained deployment, then expand — exactly how dgm structures enterprise engagements. Adoption across thousands of clinicians is its own discipline (see AI Adoption & Change Management).
How dgm helps
dgm implements osFoundry and other AI for US hospitals and health systems — within HIPAA-appropriate controls, governed by design, and rolled out pilot-to-scale. Pricing is fixed and public: a $399 assessment and a $3,999/month baseline, scope defined up front, no per-seat fees. If your teams want to explore the platform first, go straight to osFoundry; if you want health-system AI done right, that’s where dgm comes in.